Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
J Clin Virol ; 55(2): 140-6, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22841750

ABSTRACT

BACKGROUND: The availability of rotavirus vaccines has resulted in an intensification of post vaccine strain surveillance efforts worldwide to gain information on the impact of vaccines on prevalence of circulating rotavirus strains. OBJECTIVES: In this study, the distribution of human rotavirus G and P types in Hungary is reported. In addition, the VP4 and VP7 genes of G1P[8] strains were sequenced to monitor if vaccine-derived strains were introduced and/or some strains/lineages were selected against. STUDY DESIGN: The study was conducted in 8 geographic areas of Hungary between 2007 and 2011. Rotavirus positive stool samples were collected from diarrheic patients mostly <5 years of age. Viral RNA was amplified by multiplex genotyping RT-PCR assay, targeting the medically most important G and P types. When needed, sequencing of the VP7 and VP4 genes was performed. RESULTS: In total, 2380 strains were genotyped. During the 5-year surveillance we observed the dominating prevalence of genotype G1P[8] (44.87%) strains, followed by G4P[8] (23.4%), G2P[4] (14.75%) and G9P[8] (6.81%) genotypes. Uncommon strains were identified in a low percentage of samples (4.12%). Phylogenetic analysis of 318 G1P[8] strains identified 55 strains similar to the Rotarix strain (nt sequence identities; VP7, up to 97.9%; VP4, up to 98.5%) although their vaccine origin was unlikely. CONCLUSIONS: Current vaccines would have protected against the majority of identified rotavirus genotypes. A better understanding of the potential long-term effect of vaccine use on epidemiology and evolutionary dynamics of co-circulating wild type strains requires continuous strain surveillance.


Subject(s)
Rotavirus Infections/epidemiology , Rotavirus Infections/virology , Rotavirus Vaccines/immunology , Rotavirus/classification , Rotavirus/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Antigens, Viral/genetics , Capsid Proteins/genetics , Child , Child, Preschool , Feces/virology , Female , Genotype , Humans , Hungary/epidemiology , Infant , Male , Middle Aged , Molecular Epidemiology , Multiplex Polymerase Chain Reaction , RNA, Viral/genetics , Rotavirus/genetics , Rotavirus Vaccines/administration & dosage , Rotavirus Vaccines/genetics , Sequence Analysis, DNA , Young Adult
2.
Acta Microbiol Immunol Hung ; 58(1): 23-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21450552

ABSTRACT

A nosocomial Hepatitis B virus (HBV) outbreak at a paediatric onco-haematology unit was investigated using molecular biological methods to determine the origin of the infections. The National Reference Laboratory of Hepatitis Viruses received seven HBsAg positive sera from patients and one from the brother of a patient. A fragment of the preS1/preS2/S genes from all samples was amplified, the PCR products were sequenced and a rooted phylogenetic tree was constructed. All nucleotide sequences from the different patients were very similar and 6 of the 8 sequences were identical, suggesting a common origin of the infections. These sequences were closely related to those amplified from a nosocomial HBV epidemic in another hospital in Hungary. The on-scene investigation revealed several malpractices. The two hospital departments had close connections and some of the patients were treated in both institutions. Present report underlines the importance of developing screening protocols for hepatitis viruses and that of the introduction of regular training programs for health care professionals in the field of hospital hygiene.


Subject(s)
Cross Infection/transmission , Cross Infection/virology , Hepatitis B virus/genetics , Hepatitis B/transmission , Hepatitis B/virology , Base Sequence , Child , Cross Infection/blood , Cross Infection/epidemiology , DNA, Viral/genetics , Disease Outbreaks , Gene Amplification , Hepatitis B/blood , Hepatitis B/epidemiology , Hepatitis B Surface Antigens/blood , Humans , Hungary/epidemiology , Male , Oncology Service, Hospital , Phylogeny , Polymerase Chain Reaction/methods , Sequence Analysis, DNA
3.
Orv Hetil ; 150(31): 1443-50, 2009 Aug 02.
Article in Hungarian | MEDLINE | ID: mdl-19617180

ABSTRACT

Vaccination is the main strategy to control severe dehydrating gastroenteritis caused by rotaviruses in early childhood. The availability of new generation rotavirus vaccines has led to an intensification of strain surveillance worldwide, in part, to gauge the impact of the possible vaccine-driven immune selection of wild-type rotavirus strains. In the present study, authors describe the strain prevalence data obtained in 2007, with the involvement of different regions of Hungary. Genomic RNA was extracted from rotavirus-positive stool samples collected mainly from children and then subjected to genotyping using multiplex RT-PCR assay. Type-specific primers targeted G1 to G4, G6, G8 to G10, and G12 VP7 specificities, and P[4], P[6], and P[8] to P[11] VP4 specificities were used. Out of 489 rotavirus-positive specimens, collected from 482 patients, 466 and 474 were successfully G and P typed, respectively, and both G and P type specificities could be assigned for 457 strains. Prevalence data showed the predominance of G4P[8] (31.5%) strains, followed by G1P[8] (28.3%), G2P[4] (19.3%), and G9P[8] (10.2%). Minority strains were G1P[4] (0.4%), G2P[8] (1.3%), G3P[9] (0.2%), G4P[6] (0.7%), G6P[9] (0.4%), G8P[8] (0.2%), G9P[4] (0.2%), G9P[6] (0.8%), and G12P[8] (0.4%). Mixed infections were found in 1.2% of the samples, while 4.9% remained partially or fully non-typified. Our data indicate that the antigen specificities of medically important rotavirus strains identified in this 1-year study are well represented in the vaccines available in the pharmaceutical private market in Hungary. Depending on the vaccination coverage achievable in the forthcoming years, the post-vaccination rotavirus strain surveillance may allow us to gain comprehensive information on the impact of rotavirus vaccines on the prevalence of circulating rotavirus strains.


Subject(s)
Gastroenteritis/epidemiology , Gastroenteritis/virology , Population Surveillance , Rotavirus Infections/epidemiology , Rotavirus Infections/prevention & control , Rotavirus Vaccines/administration & dosage , Rotavirus/isolation & purification , Child, Preschool , Feces/virology , Female , Humans , Hungary/epidemiology , Infant , Male , Polymerase Chain Reaction , RNA, Viral/isolation & purification , Rotavirus/genetics , Rotavirus/immunology , Seasons
4.
Acta Microbiol Immunol Hung ; 53(2): 135-44, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16956125

ABSTRACT

The ARTEMIS Global Antifungal Susceptibility Program provides the collection of epidemiological data and the results of the fluconazole and voriconazole susceptibility testing of yeast isolates. Participating in this study, a total of 7318 clinical yeast isolates were tested from different geographical areas in Hungary in the period 2001 to 2003. The species isolated most frequently was C. albicans (68.8%), followed by C. glabrata (11.8%), C. tropicalis (5.7%) and C. krusei (4.6%). Isolates of C. albicans, C. kefyr, C. lusitaniae, C. tropicalis and C. parapsilosis were highly susceptible to fluconazole (78.9-100%). The rates of isolation of fluconazole-resistant C. glabrata and C. krusei were higher in our study than the global mean in 2001 (28.2% and 87.5% vs. 18.3% and 70.2%, respectively). Differences were detected in the distribution of fluconazole-susceptibility data of C. glabrata isolates in the different counties of Hungary: most of the resistant isolates were observed in the eastern part of the country.


Subject(s)
Candida/drug effects , Fluconazole/pharmacology , Microbial Sensitivity Tests/methods , Pyrimidines/pharmacology , Triazoles/pharmacology , Candida/isolation & purification , Candidiasis/microbiology , Humans , Image Processing, Computer-Assisted , Microscopy, Video/methods , Voriconazole
SELECTION OF CITATIONS
SEARCH DETAIL
...